Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Farnier

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
The American Journal of Cardiology|October 24, 2007
Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemiaEvan A Stein, John Amerena, Christie M Ballantyne, et al.
Atherosclerosis. Supplements|February 16, 2021
Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway projectUlf Landmesser, Angela Pirillo, Michel Farnier, et al.
Archives of Internal Medicine|May 25, 2005
Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarctionMarianne Zeller, Philippe Gabriel Steg, Jack Ravisy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of EvolocumabAurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
Journal of the American College of Cardiology|November 13, 2007
High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarctionMarianne Zeller, David Masson, Michel Farnier, et al.
Atherosclerosis|October 12, 2023
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlookVikrama Raja, Carlos Aguiar, Nasreen Alsayed, et al.
Atherosclerosis|October 4, 2011
Circulating leukocyte telomere length and oxidative stress: a new target for statin therapySebastien Saliques, Jean-Raymond Teyssier, Catherine Vergely, et al.
Journal of Clinical Lipidology|June 13, 2020
Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction programNicolas Danchin, Michel Farnier, Marianne Zeller, et al.
La Revue Du Praticien|December 5, 2018
[Management of dyslipidemia in adult]Sophie Béliard, Fabrice Bonnet, Béatrice Bouhanick, et al.
European Heart Journal|October 30, 2016
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular riskUlf Landmesser, M. John Chapman, Michel Farnier, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|October 24, 2007
Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemiaEvan A Stein, John Amerena, Christie M Ballantyne, et al.
Atherosclerosis. Supplements|February 16, 2021
Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway projectUlf Landmesser, Angela Pirillo, Michel Farnier, et al.
Archives of Internal Medicine|May 25, 2005
Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarctionMarianne Zeller, Philippe Gabriel Steg, Jack Ravisy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of EvolocumabAurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
Journal of the American College of Cardiology|November 13, 2007
High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarctionMarianne Zeller, David Masson, Michel Farnier, et al.
Atherosclerosis|October 12, 2023
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlookVikrama Raja, Carlos Aguiar, Nasreen Alsayed, et al.
Atherosclerosis|October 4, 2011
Circulating leukocyte telomere length and oxidative stress: a new target for statin therapySebastien Saliques, Jean-Raymond Teyssier, Catherine Vergely, et al.
Journal of Clinical Lipidology|June 13, 2020
Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction programNicolas Danchin, Michel Farnier, Marianne Zeller, et al.
La Revue Du Praticien|December 5, 2018
[Management of dyslipidemia in adult]Sophie Béliard, Fabrice Bonnet, Béatrice Bouhanick, et al.
European Heart Journal|October 30, 2016
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular riskUlf Landmesser, M. John Chapman, Michel Farnier, et al.
Pageof 15